MCAI
IMPV

Meritech Capital Associates III’s Imperva, Inc. IMPV Stock Holding History

Meritech Capital Associates III’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-189,580
Closed -$5.45M – 7
2014
Q3 		$5.45M Sell
189,580
-112,500
-37% -$3.05M 1.54% 7
2014
Q2 		$7.91M Hold
302,080
– – 2.15% 7
2014
Q1 		$16.8M Sell
302,080
-112,700
-27% -$6.48M 4.18% 5
2013
Q4 		$20M Sell
414,780
-29,600
-7% -$1.25M 3.52% 6
2013
Q3 		$18.7M Sell
444,380
-37,026
-8% -$1.76M 2.7% 7
2013
Q2 		$21.7M Buy
+481,406
New +$18.9M 5.14% 6

Other funds holding IMPV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
ACM
Andor Capital Management Rye Brook, New York $232M AUM 22.72% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Meritech Capital Associates III's IMPV Position: Q4 2014 in Review

Meritech Capital Associates III sold out of Imperva, Inc. (IMPV) in Q4 2014, closing a stake of 189,580 shares — an estimated $5.45M sold.

Meritech Capital Associates III first reported a position in IMPV in Q2 2013 and held it in 6 quarters. The position peaked at $21.7M in Q2 2013. 137 funds tracked by Wall St. Rank hold IMPV as of Q4 2014.

  • Meritech Capital Associates III reported no remaining Imperva, Inc. position as of Q4 2014 after selling out during the quarter.
  • Meritech Capital Associates III sold 189,580 Imperva, Inc. shares in Q4 2014, an estimated $5.45M.
  • Meritech Capital Associates III first reported a position in Imperva, Inc. in Q2 2013 and held it in 6 quarters.
  • Meritech Capital Associates III's Imperva, Inc. position peaked at $21.7M in Q2 2013.
  • 137 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2014.

Based on Meritech Capital Associates III's 13F filing for Q4 2014, filed 17 Feb 2015.